You Searched For "covid and stocks" and got 19 results
Sort By:
Energy stocks plummet amid oil sell-off driven by threats of boosted production
The National Oil Corporation of Libya said it would double its production to 1 million barrels per …
Matthew Fox
Chinese stocks look ready to outperform with COVID-easing catalysts on deck, Europe's top asset manager says
Amundi, which oversees more than $2 trillion in assets, is now bullish on Chinese stocks after cutt…
Hamza Fareed Malik
Pandemic-related stocks from Zoom to Moderna jump as new coronavirus variant raises alarms and triggers lockdowns
The stock prices of vaccine makers Moderna and Pfizer surged Friday along with stay-at-home stocks …
Isabelle Lee
A prolonged COVID-19 pandemic could lead to a sharp correction in the stock market, IMF warns
"If the economic recovery is delayed, there is a risk of a sharp adjustment in asset prices or peri…
Matthew Fox
Novavax surges 15% after it begins phase 3 trial of COVID-19 vaccine
In the scenario that Novavax succeeds in developing a successful COVID-19 vaccine candidate, it is …
Matthew Fox
Pfizer's CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial
The 52-week high for Pfizer stock is $41.99, which means CEO Albert Bourla sold his shares at close…
Shalini Nagarajan
Stock ban showdown in Congress delayed after Rep. Zoe Lofgren gets COVID-19
The March 16 hearing hasn't yet been rescheduled as debate over congressional stock trading heats u…
Kimberly Leonard
Global stocks trade at record highs on vaccine hopes and chances of fresh US stimulus
A series of rolling blackouts took around 1 million barrels of oil production offline and closed re…
Shalini Nagarajan
Moderna soars 16% after announcing plans to file for emergency use authorization as results indicate its COVID-19 vaccine is 94% effective
Moderna said the vaccine was more than 94% effective at preventing people in its late-stage trial f…
Shalini Nagarajan
Delta variant's spread prompted one in three traders to change their investing strategy, Charles Schwab finds
An increase in exposure to stocks, cash or fixed-income assets were the three most popular changes …
Sophie Kiderlin
Global stocks hover below record highs ahead of US inflation data, while oil falls for a 2nd day as demand optimism fades
The growth rate of weekly COVID-19 cases is currently at its slowest since mid-March, according to …
Shalini Nagarajan
Moderna, BioNtech surge as COVID-19 vaccine development progresses amid virus spike
BioNtech and Pfizer have already produced millions of doses of its vaccine so it can deliver on pre…
Matthew Fox
Moderna surges 9% after California authorizes vaccine batch following allergy scare
State epidemiologist Dr. Erica Pan said the state found "no scientific basis to continue the pause"…
Will Daniel
Peloton drops as Wedbush downgrades the fitness company on concerns gym reopenings will boost competition
Wedbush cut its 12-month price target for the high-end equipment maker's stock to $115 from $130 pe…
Carla Mozée
Global stocks rise ahead of a $908 billion pandemic relief bill reaching Congress and the US rolls out the first COVID-19 vaccines
US lawmakers plan to divide the coronavirus relief plan into two proposals in order to be voted on …
Shalini Nagarajan
Sell stocks into strength on any COVID-19 vaccine news as 2021 turns into a bear market, BofA says
The good news for investors is that opportunities will persist despite a potentially weak stock mar…
Matthew Fox
Investors should rotate away from tech stocks and into these 4 sectors before 2021 brings market relief from turmoil, a Wall Street investment chief says
Right now there is a lot of uncertainty in the markets, but "there's a lot to look forward to," sai…
Emily Graffeo
Moderna extends 2-day gain to 32% after it says Omicron vaccine will be ready in early 2022
"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really…
Matthew Fox
Novavax spikes 76% after UK study shows its COVID-19 vaccine is 89% effective
Shares of Novavax soared more than 2,700% since the company advanced the development of its novel C…